0001415889-25-023907.txt : 20250908 0001415889-25-023907.hdr.sgml : 20250908 20250908185536 ACCESSION NUMBER: 0001415889-25-023907 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250904 FILED AS OF DATE: 20250908 DATE AS OF CHANGE: 20250908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cui Xiangmin CENTRAL INDEX KEY: 0001487815 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38024 FILM NUMBER: 251301250 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: NO. 14 EAST HUSHAN ROAD STREET 2: TAI'AN CITY CITY: SHANDONG PROVINCE COUNTRY: F4 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Decheng Capital China Life Sciences USD Fund II, L.P. CENTRAL INDEX KEY: 0001650291 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38024 FILM NUMBER: 251301253 BUSINESS ADDRESS: STREET 1: MAPLES CORPORATE SERVICES, UGLAND HOUSE STREET 2: PO BOX 309, SOUTH CHURCH ST, GEORGE TOWN CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 345-949-8066 MAIL ADDRESS: STREET 1: MAPLES CORPORATE SERVICES, UGLAND HOUSE STREET 2: PO BOX 309, SOUTH CHURCH ST, GEORGE TOWN CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Decheng Capital China Life Sciences USD Fund III, L.P. CENTRAL INDEX KEY: 0001736814 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38024 FILM NUMBER: 251301255 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, PO BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 345-949-8066 MAIL ADDRESS: STREET 1: UGLAND HOUSE, PO BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Decheng Capital Global Healthcare GP, LLC CENTRAL INDEX KEY: 0001949027 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38024 FILM NUMBER: 251301251 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, PO BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: (345) 949-8066 MAIL ADDRESS: STREET 1: UGLAND HOUSE, PO BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Decheng Capital Management III (Cayman), LLC CENTRAL INDEX KEY: 0001747821 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38024 FILM NUMBER: 251301254 BUSINESS ADDRESS: STREET 1: PO BOX 309 STREET 2: UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 345-949-8066 MAIL ADDRESS: STREET 1: PO BOX 309 STREET 2: UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Decheng Capital Global Healthcare Fund (Master), LP CENTRAL INDEX KEY: 0001949026 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38024 FILM NUMBER: 251301252 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, PO BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: (345) 949-8066 MAIL ADDRESS: STREET 1: UGLAND HOUSE, PO BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BeyondSpring Inc. CENTRAL INDEX KEY: 0001677940 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR STREET 2: SUITE 410 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: 646-528-4184 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR STREET 2: SUITE 410 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 4 1 form4-09082025_100931.xml X0508 4 2025-09-04 0001677940 BeyondSpring Inc. BYSI 0001736814 Decheng Capital China Life Sciences USD Fund III, L.P. C/O DECHENG CAPITAL 3000 SAND HILL ROAD, BLDG. 2, SUITE 110 MENLO PARK CA 94025 false false true false 0001747821 Decheng Capital Management III (Cayman), LLC C/O DECHENG CAPITAL 3000 SAND HILL ROAD, BLDG. 2, SUITE 110 MENLO PARK CA 94025 0 0 1 0 0001650291 Decheng Capital China Life Sciences USD Fund II, L.P. C/O DECHENG CAPITAL 3000 SAND HILL ROAD, BLDG. 2, SUITE 110 MENLO PARK CA 94025 0 0 1 0 0001949026 Decheng Capital Global Healthcare Fund (Master), LP C/O DECHENG CAPITAL 3000 SAND HILL ROAD, BLDG. 2, SUITE 110 MENLO PARK CA 94025 0 0 1 0 0001949027 Decheng Capital Global Healthcare GP, LLC C/O DECHENG CAPITAL 3000 SAND HILL ROAD, BLDG. 2, SUITE 110 MENLO PARK CA 94025 0 0 1 0 0001487815 Cui Xiangmin C/O DECHENG CAPITAL 3000 SAND HILL ROAD, BLDG. 2, SUITE 110 MENLO PARK CA 94025 0 0 1 0 0 Ordinary Shares 2025-09-04 4 S 0 803 1.82 D 1903952 I By Decheng Capital China Life Sciences USD Fund III, L.P. Ordinary Shares 2025-09-05 4 S 0 1106 1.86 D 1902846 I By Decheng Capital China Life Sciences USD Fund III, L.P. Ordinary Shares 2025-09-08 4 S 0 7090 1.93 D 1895756 I By Decheng Capital China Life Sciences USD Fund III, L.P. Ordinary Shares 1617409 I By Decheng Capital China Life Sciences USD Fund II, L.P. Ordinary Shares 891734 I By Decheng Capital Global Healthcare Fund (Master), LP The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. ("Fund III"). Decheng Capital Management III (Cayman), LLC ("GP III") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.82 to $1.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These securities are held directly by Decheng Capital China Life Sciences USD Fund II, L.P. ("Fund II"). Decheng Capital Management II (Cayman), LLC ("GP II") is the general partner of Fund II. Dr. Cui is the manager of GP II. Each of Fund II, GP II and Dr. Cui may be deemed to beneficially own the securities held by Fund II. Each of GP II and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein. These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP ("Healthcare"). Decheng Capital Global Healthcare GP, LLC ("Healthcare GP") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein. Decheng Capital China Life Sciences USD Fund III, L.P., By Decheng Capital Management III (Cayman), LLC, its General Partner, By /s/ Xiangmin Cui, Manager 2025-09-08 Decheng Capital Management III (Cayman), LLC, By /s/Xiangmin Cui, Manager 2025-09-08 Decheng Capital China Life Sciences USD Fund II, L.P., By Decheng Capital Management II (Cayman), LLC, its General Partner, By /s/ Xiangmin Cui, Manager 2025-09-08 Decheng Capital Global Healthcare Fund (Master), LP, By Decheng Capital Global Healthcare GP, LLC, its General Partner, By Decheng Capital LLC, its Manager, By /s/ Xiangmin Cui, Manager 2025-09-08 Decheng Capital Global Healthcare GP, LLC, By Decheng Capital LLC, its Manager, By /s/ Xiangmin Cui, Manager 2025-09-08 /s/ Xiangmin Cui 2025-09-08